A Trial of HR091506 Tablets in Treatment of Primary Gout With Hyperuricemia in Adults
Status:
Not yet recruiting
Trial end date:
2022-07-31
Target enrollment:
Participant gender:
Summary
The study is being conducted to evaluate the efficacy and safety of HR091506 tablets for
treatment of primary gout with hyperuricemia in adults, and to compare the results with
febuxostat tablets in the same doses.